Inventor · disambiguated record
Min Hyo Ki
Also filed as: KI MIN-HYO
8 granted patents·14 pending applications·29 citations·filing 1998–2025
80Inventor score
Files withSAMJIN PHARM CO LTD7CHONG KUN DANG PHARM CORP6CHONG KUN DANG PHARMACEUTICAL CORP3APTABIO THERAPEUTICS INC2CHONG KUN DANG CORP1
Top patents by PatentIndex Score
22 records- 0190US9173853B2Composition for gene deliveryCHONG KUN DANG PHARM CORP·Filed 2012·Granted Nov 3, 2015·18 cites·8 claims
- 0271US7229980B2Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or derivative thereofCHONG KUN DANG PHARM CORP·Filed 2005·Granted Jun 12, 2007·2 cites·15 claims
- 0369US9526787B2Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the sameKO JIN YOUNG·Filed 2012·Granted Dec 27, 2016·2 cites·17 claims
- 0466US10722585B2Sustained-release lipid pre-concentrate of GNRH analogues and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2013·Granted Jul 28, 2020·1 cites·24 claims
- 0565US2025304612A1Therapeutic agent for blood cancerAPTABIO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0659US2025230131A1Novel ionizable lipid and lipid nanoparticle composition using sameMEDICIBIO CO LTD·Filed 2023·Application pending·0 cites
- 0757US2025281472A1Ophthalmic composition inhibiting occurrence of n-oxopyridine compound for preventing or treating eye diseaseSAMJIN PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0851US10918725B2Ophthalmic composition comprising rebamipide and method for preparing the sameSAMJIN PHARM CO LTD·Filed 2016·Granted Feb 16, 2021·0 cites·7 claims
- 0951US2006177500A1Solid dispersion of tacrolimusSHIN HEE-JONG·Filed 2004·Application pending·0 cites
- 1050US11318215B2Composition for gene delivery comprising chitosan and liquid crystal formation materialCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2014·Granted May 3, 2022·0 cites·12 claims
- 1150US2023192752A1Therapeutic agent for blood cancerAPTABIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1250US2006019872A1Oral formulations for poorly absorptive hydrophilic drugsCHONG KUN DANG PHARM CORP·Filed 2003·Application pending·0 cites
- 1349US2023025836A1Eye drop composition for preventing or treating eye diseaseSAMJIN PHARM CO LTD·Filed 2020·Application pending·0 cites
- 1446US2021393642A1Composition for preventing or treating sjogren's syndromeSAMJIN PHARM CO LTD·Filed 2019·Application pending·0 cites
- 1546US2022218685A1Composition for treating eye diseasesSAMJIN PHARM CO LTD·Filed 2020·Application pending·0 cites
- 1643US2008226579A1Novel Resinate Complex of S-Clopidogrel and Production Method ThereofCHONG KUN DANG PHARM CORP·Filed 2006·Application pending·0 cites
- 1743US2015290322A1Sustained-release lipid pre-concentrate of anionic pharmacologically active substances and pharmaceutical composition comprising the sameCHONG KUN DANG PHARM CORP·Filed 2013·Application pending·0 cites
- 1842US2015265535A1Sustained-release lipid pre-concentrate of cationic pharmacologically active substance and pharmaceutical composition comprising the sameCHONG KUN DANG PHARM CORP·Filed 2013·Application pending·0 cites
- 1941US10844062B2Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereofSAMJIN PHARM CO LTD·Filed 2017·Granted Nov 24, 2020·0 cites·7 claims
- 2040US6048540AAcetamenophen composition with reduced liver toxicityCHONG KUN DANG CORP·Filed 1998·Granted Apr 11, 2000·6 cites·13 claims
- 2134US2019038564A1Carvedilol Immediate Release Formulation Having Improved MadescentSAMJIN PHARM CO LTD·Filed 2017·Application pending·0 cites
- 2227US2018207146A1Pharmaceutical composition comprising 5alpha-reductase inhibitorCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Min Hyo Ki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →